Scientific Posters

Case studies on the characterization & clinical development of agonistic antibody therapeutics targeting checkpoint receptors.

The clinical success of an ever-increasing array of biologics has led to the development of a wide spectrum of immunomodulatory…

DiscoveRx offers an industry-leading portfolio of over 600 naturally coupled human and ortholog G-protein coupled receptor (GPCR) cell lines designed…

A common feature of 7TM receptors is that upon activation, the receptors are bound by cellular Arrestin proteins. DiscoveRx has…

DiscoveRx’s PathHunter® platform is a simple, cell-based, chemiluminescent assay format that allows for screening large numbers of small molecules or…

Drug efficacy and cellular target engagement studies have traditionally been monitored by evaluation of downstream cellular responses, such as detection…

DiscoveRx has developed a panel of over 120 characterized GPCR cell lines that monitor receptor activity using interaction with human…

Biologics represents one of the fastest growing classes of biopharmaceutical molecules today. One of the major bottlenecks in the development…

Monoclonal antibodies (MAbs) represent one of the fastest growing classes of biotherapeutic molecules today. While many technologies exist for generating…

There is an increasing need to generate therapeutics targeting metabolic and gastrointestinal diseases to address the global burden of metabolic…

Interleukins are known for their involvement in functioning of both the adaptive and innate immune systems. Interleukins direct immune cells…

One of the major bottlenecks in the development of biosimilars is the need for good bioassays to create potency, stability…